These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17564957

  • 1. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.
    Dórea JG.
    Am J Perinatol; 2007 Aug; 24(7):387-400. PubMed ID: 17564957
    [Abstract] [Full Text] [Related]

  • 2. Changes in children hair-Hg concentrations during the first 5 years: maternal, environmental and iatrogenic modifying factors.
    Marques RC, Dórea JG, Bastos WR, Malm O.
    Regul Toxicol Pharmacol; 2007 Oct; 49(1):17-24. PubMed ID: 17566620
    [Abstract] [Full Text] [Related]

  • 3. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.
    Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
    [Abstract] [Full Text] [Related]

  • 4. Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.
    Marques RC, Dórea JG, Fonseca MF, Bastos WR, Malm O.
    Eur J Pediatr; 2007 Sep; 166(9):935-41. PubMed ID: 17237965
    [Abstract] [Full Text] [Related]

  • 5. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months.
    Dórea JG, Marques RC.
    J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):598-601. PubMed ID: 20010978
    [Abstract] [Full Text] [Related]

  • 6. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ.
    Vaccine; 2004 May 07; 22(15-16):1854-61. PubMed ID: 15121295
    [Abstract] [Full Text] [Related]

  • 7. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ, McIntyre PB.
    Expert Opin Drug Saf; 2006 Jan 07; 5(1):17-29. PubMed ID: 16370953
    [Abstract] [Full Text] [Related]

  • 8. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.
    Pediatrics; 2010 Oct 07; 126(4):656-64. PubMed ID: 20837594
    [Abstract] [Full Text] [Related]

  • 9. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.
    Bigham M, Copes R, Srour L.
    Can Commun Dis Rep; 2002 May 01; 28(9):69-80. PubMed ID: 12012653
    [No Abstract] [Full Text] [Related]

  • 10. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
    Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.
    Acta Paediatr; 2007 Jun 01; 96(6):864-8. PubMed ID: 17465985
    [Abstract] [Full Text] [Related]

  • 11. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Vaccine Safety Datalink Team.
    N Engl J Med; 2007 Sep 27; 357(13):1281-92. PubMed ID: 17898097
    [Abstract] [Full Text] [Related]

  • 12. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J, Golding J, ALSPAC Study Team.
    Pediatrics; 2004 Sep 27; 114(3):577-83. PubMed ID: 15342824
    [Abstract] [Full Text] [Related]

  • 13. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years.
    Marques RC, Dórea JG, Bernardi JV, Bastos WR, Malm O.
    Cogn Behav Neurol; 2009 Jun 27; 22(2):134-41. PubMed ID: 19506431
    [Abstract] [Full Text] [Related]

  • 14. Automated speciation of mercury in the hair of breastfed infants exposed to ethylmercury from thimerosal-containing vaccines.
    Dórea JG, Wimer W, Marques RC, Shade C.
    Biol Trace Elem Res; 2011 Jun 27; 140(3):262-71. PubMed ID: 20419397
    [Abstract] [Full Text] [Related]

  • 15. [Mercury in vaccines].
    Hessel L.
    Bull Acad Natl Med; 2003 Jun 27; 187(8):1501-10. PubMed ID: 15146581
    [Abstract] [Full Text] [Related]

  • 16. Mercury and lead during breast-feeding.
    Dorea JG.
    Br J Nutr; 2004 Jul 27; 92(1):21-40. PubMed ID: 15230985
    [Abstract] [Full Text] [Related]

  • 17. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
    Marques RC, Dórea JG, Bernardi JV.
    Acta Paediatr; 2010 Jun 27; 99(6):934-9. PubMed ID: 20003103
    [Abstract] [Full Text] [Related]

  • 18. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
    Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT, Vaccine Safety Datalink Team.
    Pediatrics; 2003 Nov 27; 112(5):1039-48. PubMed ID: 14595043
    [Abstract] [Full Text] [Related]

  • 19. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG, Marques RC, Brandão KG.
    Am J Perinatol; 2009 Aug 27; 26(7):523-7. PubMed ID: 19283656
    [Abstract] [Full Text] [Related]

  • 20. An assessment of thimerosal use in childhood vaccines.
    Ball LK, Ball R, Pratt RD.
    Pediatrics; 2001 May 27; 107(5):1147-54. PubMed ID: 11331700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.